Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

QR Code

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

Mª del Carmen Álamo,1 Sebastian Ochenduszko,2 Guillermo Crespo,3 Mónica Corral,4 Juana Oramas,5 Pilar Sancho,6 Javier Medina,7 Fernando Garicano,8 Pedro López,9 Begoña Campos Balea,10 Analia Rodríguez Garzotto,11 Eva Muñoz-Couselo12,13 1Oncology Department, Hospital Universitario Virgen Macarena, Se...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Álamo MC, Ochenduszko S, Crespo G, Corral M, Oramas J, Sancho P, Medina J, Garicano F, López P, Campos Balea B, Rodríguez Garzotto A, Muñoz-Couselo E
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	vemurafenib cobimetinib braf metastatic melanoma durable response clinical practice Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/c4c4575b8a5f4a8b85e34e1b4211b469
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
par: Stefanie Hoyer, et autres
Publié: (2021)

BRAF Mutation Status in Primary, Recurrent, and Metastatic Malignant Melanoma and Its Relation to Histopathological Parameters
par: Aris Spathis, et autres
Publié: (2019)

Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma
par: Nika Filipović, et autres
Publié: (2021)

BRAF-Inhibitor-Induced Metabolic Alterations in A375 Melanoma Cells
par: Prashant Karki, et autres
Publié: (2021)

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
par: Hima Patel, et autres
Publié: (2021)

Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models
par: Mario Sechi, et autres
Publié: (2018)

Early Experience with Dabrafenib–Trametinib Combination in Patients with BRAF-Mutated Malignant Melanoma—A Single-Center Experience
par: Sandip Ganguly, et autres
Publié: (2021)

Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
par: Gkiala A, et autres
Publié: (2020)

Relevance of BRAF Subcellular Localization and Its Interaction with <i>KRAS</i> and <i>KIT</i> Mutations in Skin Melanoma
par: Marius-Alexandru Beleaua, et autres
Publié: (2021)

Treatment of Advanced Metastatic Melanoma
par: Pietro Quaglino, et autres
Publié: (2021)

Seven Synchronous Primary Melanomas on the Back
par: Sanja Javor, et autres
Publié: (2021)

Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study
par: Graham W. Sivyer, et autres
Publié: (2014)

Metastatic melanoma with sebocyte-like melanocytes and widespread visceral involvement
par: Li-Wei Chang, et autres
Publié: (2020)

Melanoma Targeted Therapies beyond <i>BRAF</i>-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
par: Karam Khaddour, et autres
Publié: (2021)

High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
par: Wan-Ru Chao, et autres
Publié: (2021)

Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
par: Vidhi Malik, et autres
Publié: (2021)

Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
par: Ali R. Jazirehi
Publié: (2021)

Explicitly Assessing the Durability of RC Structures Considering Spatial Variability and Correlation
par: Cao Wang
Publié: (2021)

Metastatic melanoma to the ovary in pregnancy: A case report
par: D.S. Huang, et autres
Publié: (2021)

Preliminary Study on the Relationship of BRAF Mutations with the Outcome of the First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma
par: Shangguan L, et autres
Publié: (2021)

A rare case of solitary gallbladder metastasis from an early cutaneous melanoma
par: Emily Louise Doole, et autres
Publié: (2021)

A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer
par: Yalikong A, et autres
Publié: (2021)

Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients
par: Vidinov K., et autres
Publié: (2021)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
par: Wu L, et autres
Publié: (2021)

Melanoma metastasis to the bladder: A case report
par: Raj A. Kumar, et autres
Publié: (2022)

In vivo reflectance confocal microscopy: a useful non-invasive tool to assess the response to isolated limb perfusion for superficial pigmented melanoma in-transit metastatic disease. Report of a case
par: Rastine Merat, et autres
Publié: (2017)

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
par: Jennifer A. Silver, et autres
Publié: (2021)

Mechanical and durability properties of the concrete with copper slag
par: Jagan,S., et autres
Publié: (2021)

The effect of composition and thermodynamics on the surface morphology of durable superhydrophobic polymer coatings
par: Nahum T, et autres
Publié: (2017)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
par: Rino S. Seedor, et autres
Publié: (2021)

SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
par: Yu. A. Khochenkova, et autres
Publié: (2014)

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma
par: Michael G. White, et autres
Publié: (2021)

The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas
par: Jan Pals, et autres
Publié: (2021)

Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification
par: Sara Moreno, et autres
Publié: (2021)

Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy
par: Wolfram Samlowski, et autres
Publié: (2021)

Domestic Gas Meter Durability in Hydrogen and Natural Gas Mixtures
par: Jacek Jaworski, et autres
Publié: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
par: Mizue Terai, et autres
Publié: (2021)

Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with <i>BRAF<sup>V600E</sup></i>-Mutant Advanced Papillary Thyroid Carcinoma
par: Eyun Song, et autres
Publié: (2021)

Improvement of the durability of heat-treated wood against termites
par: Salman,Solafa, et autres
Publié: (2017)

Durability of Pinus elliottii Wood Impregnated with Quebracho Colorado (Schinopsis balansae) Bio-Protectives Extracts and CCA
par: Bernardi,Aldo C, et autres
Publié: (2009)